
The risk of developing gestational diabetes was similar between both group prenatal care and traditional individual prenatal care, however, group care may benefit some patients as a treatment option.
Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
The risk of developing gestational diabetes was similar between both group prenatal care and traditional individual prenatal care, however, group care may benefit some patients as a treatment option.
SSRI treatment for postnatal depression brought long-term benefits for mothers and their offspring in the following years after childbirth, study findings showed.
Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.
Any new prices established after negotiations will be effective on January 1, 2026.
KET01 could successfully treat treatment-resistant depression while limiting adverse effects in the home environment, according to the study.
The recent discovery could aid further research on the cause of Huntington’s disease and other inherited conditions.
The phase 3 study will advance the safety findings of survodutide reported in the phase 2 study to aid overweight and obesity.
Session at NACDS Total Store Expo leadership discusses NACDS initiatives and world events.
Session at NACDS Total Store Expo discusses how pharmacies can leverage their accessibility to decrease diet-related diseases through health and wellness.
Session at NACDS Total Store Expo discusses how to address shortcomings in women’s health areas in the health and wellness industry.
Session at NACDS Total Store Expo discusses minor changes that retail companies can make to mesh artificial intelligence into their work to increase sales, improve margins, and lower costs.
Policy efforts must be put in place to support HCV treatment for all individuals to reduce the disparities in direct-acting antiviral treatment.
No major changes were found in overdose behaviors among individuals who received take-home naloxone.
The findings suggest that varying precautions and factors affected the transmission rates in schools in different periods of the pandemic.
Updated guidelines, comprehensive review, and an investment of resources into pediatric preventive cardiology programs could help provide successful care.
The findings suggest that CHD1L’s could provide treatment opportunities for individuals infected with HIV-1.
Social jet lag could create adverse health impacts that a 90-minute difference in the mid-point of sleep can improve.
The findings suggest that cigarette smoking is an independent predictor for the expansion of hematoma, although smoking status does not cause a difference in mortality.
Of the individuals that participated in the study, 65.3% reported hearing loss at 71 years and 96.2% reported hearing loss by 90 years.
The common diabetes drug could mediate hyperglycemia, which is caused when SARS-CoV-2 infects hepatocytes.
The findings suggest that individuals who consume alcohol will have high blood pressure over time compared to non-drinkers.
Study shows maternal vaccination with Pfizer’s hexavalent capsular polysaccharide conjugate vaccine may protect infants against Group B Streptococcus.
The data could inform how non–steroidal anti-inflammatory drug-mediated mitochondrial uncoupling could affect other diseases.
The research narrows the most at-risk populations and how to mitigate the impacts on adults with ADRD.
Amivantamab-vmjw in combination with chemotherapy could assist patients diagnosed with non–small cell lung cancer when chemotherapy alone did not show benefit.
Individuals with age-related hearing loss should not be treated with “standard” hearing aids, but fitted to their personal needs, while avoiding settings that add distortion.
The findings could help in future vaccine prioritization strategies and therapeutic allocation policies for other pandemic.
Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular lymphoma.
Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.
A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.